Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al

Pomme B. M. Poppelaars; Lilian H. D. van Tuyl; Maarten Boers

doi:https://doi.org/10.1136/annrheumdis-2019-215863

Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al

Pomme B. M. Poppelaars, Lilian H. D. van Tuyl, Maarten Boers

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Article number	e125
Journal	Annals of the rheumatic diseases
Volume	79
Issue number	10
Early online date	8 Jul 2019
DOIs	https://doi.org/10.1136/annrheumdis-2019-215863
Publication status	Published - 1 Oct 2020

Keywords

disease activity
early rheumatoid arthritis
treatment

Access to Document

https://doi.org/10.1136/annrheumdis-2019-215863

Cite this

Poppelaars, P. B. M., van Tuyl, L. H. D., & Boers, M. (2020). Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al. Annals of the rheumatic diseases, 79(10), Article e125. https://doi.org/10.1136/annrheumdis-2019-215863

Poppelaars, Pomme B. M. ; van Tuyl, Lilian H. D. ; Boers, Maarten. / Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al : Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al. In: Annals of the rheumatic diseases. 2020 ; Vol. 79, No. 10.

@article{1e4152828ba3465ab6231f928399dacc,

title = "Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: {\^A} € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al",

keywords = "disease activity, early rheumatoid arthritis, treatment",

author = "Poppelaars, {Pomme B. M.} and {van Tuyl}, {Lilian H. D.} and Maarten Boers",

year = "2020",

month = oct,

day = "1",

doi = "https://doi.org/10.1136/annrheumdis-2019-215863",

language = "English",

volume = "79",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "10",

}

Poppelaars, PBM, van Tuyl, LHD & Boers, M 2020, 'Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al', Annals of the rheumatic diseases, vol. 79, no. 10, e125. https://doi.org/10.1136/annrheumdis-2019-215863

Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al. / Poppelaars, Pomme B. M.; van Tuyl, Lilian H. D.; Boers, Maarten.
In: Annals of the rheumatic diseases, Vol. 79, No. 10, e125, 01.10.2020.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al

T2 - Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al

AU - Poppelaars, Pomme B. M.

AU - van Tuyl, Lilian H. D.

AU - Boers, Maarten

PY - 2020/10/1

Y1 - 2020/10/1

KW - disease activity

KW - early rheumatoid arthritis

KW - treatment

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068538831&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31285259

U2 - https://doi.org/10.1136/annrheumdis-2019-215863

DO - https://doi.org/10.1136/annrheumdis-2019-215863

M3 - Comment/Letter to the editor

C2 - 31285259

SN - 0003-4967

VL - 79

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 10

M1 - e125

ER -

Poppelaars PBM, van Tuyl LHD, Boers M. Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al: Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al. Annals of the rheumatic diseases. 2020 Oct 1;79(10):e125. Epub 2019 Jul 8. doi: https://doi.org/10.1136/annrheumdis-2019-215863

Keywords

Access to Document

Other files and links

Cite this